ResMed | RMD - 流动负债

金融业

USD

USD 8.97B

现金及等价物

USD 1.47B

USD 612.93M

USD 4.32B

USD 1.4B

USD 843.17M

股息收益率

0.28

USD 454.34M

USD 559.78M

10.6K

EPS每股收益

USD 2.95

股本和储备

USD 6.59B

USD 861.22M

债务利息支出

USD 8.79M

USD 59K

USD 399.42M

USD 35.17B

USD 383.43M

USD 1.01B

USD 454.34M

普通股股本

USD 145.06M

18.29

USD 502.31M

USD 1.46B

销售和管理费用

USD 290.66M

USD 945.81M

贸易债权人

USD 308.92M

应收帐款人

USD 1.04B

	流动负债	更改		日
Ansell	USD 468.9M		53.1M	2025-12
Artivion	USD 106.93M		14.23M	2026-06
AtriCure	USD 81.92M		8.72M	2026-06
Baxter International	USD 3.59B		102M	2026-06
Cochlear	AUD 558.9M		43.4M	2025-12
Cooper Companies	USD 1.8B		209M	2026-03
CSL	USD 4.61B		207M	2025-12
Dexcom	USD 2.36B		133.9M	2026-06
Edwards Lifesciences	USD 1.51B		98.9M	2026-06
Fisher Paykel Healthcare	NZD 497.8M		26.5M	2026-06
Globus Medical	USD 479.35M		3.12M	2026-06
Haemonetics	USD 263.24M		19.36M	2026-06
Idexx Laboratories	USD 1.29B		12.19M	2026-06
Inogen	USD 64.94M		2.12M	2025-09
Insulet	USD 744.2M		56.7M	2026-06
Integra LifeSciences	USD 330.88M		15.96M	2026-06
Intuitive Surgical	USD 2.58B		65.1M	2026-06
Medtronic	USD 11.66B		2.16B	2026-03
Philips	EUR 7.42B		8M	2026-06
Ramsay Health Care	AUD 3.95B		514.2M	2025-12
ResMed	USD 1.4B		43.9M	2026-06
Sigma Healthcare	AUD 1.7B		1.33B	2025-12
Sonic Healthcare	AUD 2.23B		92.84M	2024-12
Steris	USD 1.28B		138.3M	2026-06
Teleflex	USD 720.38M		7.67M	2026-06
Thermo Fisher Scientific	USD 15.07B		448M	2026-06